Nonreceptor tyrosine kinase Abl is an actin-binding protein and a key regulator of neuronal axonal development. Although Abl family kinases also are localized in dendrites and are implicated in postsynaptic functions, it is not clear how Abl kinases regulate dendritic morphogenesis. Using a developing hippocampal culture as a model, we found that the inhibition of Abl kinases by STI571 leads to a remarkable simplification of dendritic branching similar to the phenotype caused by an increased activity of small GTPase RhoA. Time-lapse microscopic imaging reveals a prominent reduction of dendritic branching. In contrast, neurons expressing a constitutively active v-abl construct (CA-Abl) show an exuberant microtubule-associated protein 2-positive (MAP2-positive) dendrite outgrowth, suggesting that Abl modulates dendritic growth. Biochemical assays using a glutathione S-transferase pull-down method to determine GTP-bound active Rho GTPases demonstrate that Abl inhibition increases RhoA activity but has no effect on the activity of Rac1 or Cdc42. At the cellular level the alteration of Abl also changes actin organization consistent with RhoA inhibition. Suppression of the RhoA downstream effector Rho kinase reverses STI571-induced dendritic simplification, demonstrating that activity of the Rho pathway is responsible for the Abl-induced changes in dendrogenesis. Furthermore, CA-Abl-induced neurite outgrowth is blocked by the expression of a constitutively active RhoA construct. The CA-Abl phenotype is not affected by destabilization of microtubules but is reversed partially when actin filaments are stabilized with jasplakinolide. Together, these studies support a critical role for Abl kinases in regulating dendrogenesis by inducing actin cytoskeletal rearrangements in cooperation with Rho GTPases.
Introduction
The development of functional circuitry in the CNS is an intricate process that relies, in part, on the morphological complexity of resident neurons. Dendrites act as integrators of synaptic input; thus the process of dendrogenesis determines the number and pattern of synapses that are received by each mature neuron (McAllister, 2000) . Development of the dendritic tree is a series of dynamic events that result in the formation of a complex and highly ordered structure through abundant remodeling and reorganization of the actin and microtubule cytoskeletons. These processes are regulated by a variety of extracellular signals, which eventually converge on signaling pathways that effect cytoskeletal reorganization (Luo, 2000; Rao and Craig, 2000; Pendergast, 2002) .
The Abl family of nonreceptor tyrosine kinases is an important link in signal transduction pathways that promote cytoskeletal rearrangement Pendergast, 2002) . During brain development Abl family kinases play an important role in neurulation, because abl/arg double-null mice exhibit defective neural tube morphology and gross alterations in neuroepithelial actin cytoskeleton structures (Koleske et al., 1998) . Abl kinases are involved additionally in moderating actin dynamics in axonogenesis and growth cone motility, and they have been shown to stimulate neurite outgrowth in primary neuronal cultures (Zukerberg et al., 2000; Woodring et al., 2002) . Abl localization also has been demonstrated in the growth cones of primary hippocampal neurons where it interacts with ␦-catenin, a dendrite-specific Abl substrate that recently has been shown to affect dendrite outgrowth and branching Martinez et al., 2003) . In addition, Abl kinases are localized to both presynaptic and postsynaptic sites in mature neurons and at the neuromuscular junction (Finn et al., 2003; . A precise function for Abl in developing dendrites, however, is undefined.
Abl kinase regulates actin-dependent processes via interactions with several protein families, including the Rho family small GTPases (Van Etten, 1999; Lanier and Gertler, 2000; Liebl et al., 2000) . For example, Abl kinases may decrease RhoA activation via the phosphorylation of an upstream Rho regulator, p190Rho GTPase-activating protein (p190RhoGAP) . Signaling pathways involving the Rho family of small GTPases mediate distinct actin cytoskeleton reorganization events in different cell types and have been proposed to be key mediators of dendritic development. In particular, expression of constitutively active RhoA inhibits dendrite growth and induces neurite retraction (Katoh et al., 1998; Lee et al., 2000; Luo, 2000; Nakayama et al., 2000) . Conversely, RhoA null mutations promote dendrite outgrowth and cause overextension of dendritic processes (Lee et al., 2000) . Active RhoA can initiate cellular process retraction by acting on Rho-associated kinase/p160/ROCK (Katoh et al., 1998) , which can be prevented by inhibition of ROCK activity (Bito et al., 2000; Da Silva et al., 2003) . Therefore, it is possible that Abl may cooperate with signaling partners of Rho family small GTPases to contribute to dendrogenesis. In this study we demonstrate that Abl family nonreceptor tyrosine kinases promote dendrogenesis via a RhoA/ROCK-dependent manner in developing hippocampal neurons.
Materials and Methods
Hippocampal cultures, transfections, and pharmacological treatments. Embryonic hippocampal cultures were prepared as described by Goslin and colleagues with minor modifications (Goslin et al., 1998; Jones et al., 2002; Lu et al., 2002) . Briefly, 18 d timed pregnant rats were killed, and the embryos were removed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Hippocampi were collected, and cells were dissociated by trypsinization and plated onto poly-L-lysine-coated coverslips in DMEM supplemented with 10% FBS. After neurons adhered to the substrate, the medium was changed to Neurobasal supplemented with B-27. This culture scheme allowed us to maintain viable low-density hippocampal cultures for several weeks.
Hippocampal neurons grown for 5 d in vitro (5 DIV) were transfected with enhanced green fluorescent protein (pEGFP; Clontech, Palo Alto, CA), using Lipofectamine 2000 reagent (Invitrogen, Grand Island, NY), according to the instructions provided. Constitutively active v-abl and constitutively active RhoA-GFP (Q36L) kindly were provided by D. Baltimore and K. Burridge, respectively. The neurons were fixed in 4% paraformaldehyde 48 hr after transfection. Alternatively, neurons were subject to 100 nM jasplakinolide (Molecular Probes, Eugene, OR) for 5 hr, 5 M vincristine (Sigma, St. Louis, MO) for 5 hr, 5 M latrunculin A (Biomol Research Laboratory, Plymouth Meeting, PA) treatment for 24 hr, or 0.03% DMSO (Sigma) treatment for 24 hr before they were fixed for immunofluorescent light microscopy. STI571/CGP15748 (or Gleevec/imatinib mesylate) kindly was provided by Novartis (Zurich, Switzerland) and was used to inhibit Abl family tyrosine kinases. AG1296, a selective inhibitor for platelet-derived growth factor (PDGF) receptor, was obtained from Calbiochem (La Jolla, CA). Y-27632 treatment (10 M) for 18 hr (Calbiochem) was used to achieve specific inhibition of ROCK.
For double-labeling experiments the neurons were treated with 0.2% Triton X-100 for 15 min, blocked with 10% BSA, and stained with rhodamine or FITC phalloidin (Molecular Probes). Antibodies (polyclonal K12 and monoclonal 24-11, Santa Cruz Biotechnology, Santa Cruz, CA; monoclonal Ab-3, Oncogene, Bedford, MA) directed against c-Abl were used to visualize cells transfected with the v-abl construct. Alternately, cells were immunostained with monoclonal anti-microtubuleassociated protein 2 (MAP2; Sigma), monoclonal anti-Tau (Tau-1, Sigma), or polyclonal anti-CD71/transferrin receptor (Santa Cruz Biotechnology). After PBS washes the coverslips were mounted and analyzed under either a Zeiss Axiovert S100 or a Zeiss LSM 510 confocal laserscanning light microscope (Carl Zeiss, Thornwood, NY). The morphometric analyses were performed with the MetaMorph 4.6 Imaging software system (Universal Imaging, West Chester, PA).
Glutathione S-transferase pull-down assays. Glutathione S-transferase (GST) pull-down assays were performed as described (Benard et al., 1999; Ren et al., 1999) . Briefly, 5 DIV cortical or hippocampal cultures were treated with 0.03% DMSO for 48 hr, 3 M STI571 for 48 hr, 10 nM Toxin B (Calbiochem) for 24 hr, 100 M hydrogen peroxide for 10 min, or 100 M L-glutamate (Sigma) for 10 min. GTP-bound RhoA, Rac1, and Cdc42 were affinity-precipitated, using the RhoA-binding domain of Rhotekin (GST-RBD) or the Rac1/Cdc42-binding domain of PAK (GST-PBD; Cytoskeleton, Denver, CO). Bound proteins were washed, resolved on 8 -16% SDS-PAGE gels, transferred to PVDF membranes (Millipore, Bedford, MA), and immunoblotted with monoclonal anti-RhoA (Cytoskeleton), monoclonal anti-Rac1 (BD Transduction Laboratories, Lexington, KY), or polyclonal anti-Cdc42 (Cytoskeleton), using enhanced chemiluminescence (Amersham Biosciences, Piscataway, NJ) for detection. Densitometric analysis of films was performed with the Bio-Rad GelDoc Imaging system (Bio-Rad Laboratories, Hercules, CA). Relative amounts of GTP-bound RhoA, Rac1, or Cdc42 for each treatment were determined by measuring the amount of RhoA, Rac1, or Cdc42 sedimented by the GST-RBD or GST-PBD relative to the total amount of RhoA, Rac1, or Cdc42 in the control (DMSO) treatment.
Time-lapse light microscopy. To determine the dynamics of dendrogenesis of a single neuron, we have applied time-lapse light microscopy according to a procedure described earlier Kim et al., 2002) . Briefly, dissociated hippocampal neurons treated with DMSO as a control or STI571 for 2 d from 5 to 7 DIV were grown on 25 mm coverslips and placed in an Attofluor cell chamber (Atto Instruments, Rockville, MD) on the heated stage of a Zeiss Axiovert microscope, which was supported by an anti-vibration table. Differential interference contrast images at 63ϫ were captured by using a Hamamatsu Orca camera (Bridgewater, NJ). To minimize phototoxicity for the living cells, we used a computer-driven automatic shutter to achieve minimum illumination (300 msec/frame). The longest continuous recording was 135 min. For some experiments, at the end of the time-lapse recording the cells were fixed and processed for Hoechst 33258 nuclear staining and anti-MAP2 immunocytochemistry to evaluate the status of neuronal cell death. The integrity of nuclear and cell morphology as well as dendritic motility indicated that the neurons were healthy throughout the incubation period. For some time-lapse experiments the neurons first were grown in normal medium for 7 d and then were placed on stage for recording. DMSO or STI571 was added for 135 min to examine the onset of dendritic deterioration caused by STI571.
In some experiments, low-density hippocampal neurons (5000/25 mm 2 ) were cultured on etched-grid coverslips (Bellco, Vineland, NJ) coated with poly-L-lysine. For this type of experiment we typically took images of ϳ3-5 neurons per coverslip at 0.5, 3, 4, 5, 6, and 7 DIV. After the neurons were imaged, they were returned to the incubator. Dishes were kept outside the incubator for Ͻ20 min on the heated stage. The etchings on the coverslips made it possible to identify the same neurons on subsequent days.
Data analysis. We used MetaMorph 4.6 (Universal Imaging) to analyze the single cell images from neurons grown on the etched coverslips and immunofluorescent light microscopy of neurons cultured on 25 mm coverslips or from the recorded time-series of neurons grown in the Attofluor chamber. Dendrite numbers were determined by using Measure Count Object function. Primary dendrites were considered when processes extended directly from the cell body, and they were scored when they were longer than 10 m. Secondary dendrites were considered when processes branched off primary dendrites, and they were scored when they were longer than 10 m. Processes shorter than 10 m were considered as sprouts. To analyze the axon and dendrite indexes (length and number of branches) on neurons grown on the etched coverslips at 25ϫ magnification, we used the total length of dendrites and their numbers. To analyze the relative dendritic complexity affected by different treatments, we determined the dendrite number and length in a bracketed area of 120 m 2 around the neurons imaged at 63ϫ magnification. For each dendrite measurement the sprouts and branches along the 80 m length of a given dendrite were scored in total of 30 neurons from at least three independent experiments. Dendrite length was determined by using Region Measurement function. Numerical values of number and length measurements were logged onto Microsoft Excel (Redmond, WA) automatically. For some analyses, when it was necessary to pool dendrite length measurements from different experiments, their values were normalized. The histories of dendrite elongation and retraction were produced by Microsoft Excel and SigmaPlot 8.0 (SPSS Science, Chicago, IL).
For immunofluorescent light microscopy of latrunculin A-treated neurons, F-actin was fragmented, and the staining was weak. The images were enhanced intentionally to reveal dendritic morphology for dendrite number and length measurement. The F-actin staining was also weak for jasplakinolide-treated neurons because of its competition with fluorescent phalloidin for F-actin binding. The images were enhanced similarly to reveal dendritic morphology for dendrite number and length measurement.
One-way ANOVA and Dunnett's procedure for means were performed, and p values were assigned in each experiment. Any null hypothesis with the probability level Ͻ95% was rejected.
Results

Inhibition of Abl family tyrosine kinases disrupts dendrogenesis independently of axonogenesis
Hippocampal neurons acquire their polarized morphology in a well characterized sequence of events (Dotti et al., 1988) . To examine what role the Abl family tyrosine kinases may play during dendrogenesis, we compared the developmental progression of primary hippocampal neurons with those cultures treated with 3 M STI571 (CGP15748/Gleevec/imatinib mesylate), a well known anti-cancer drug widely used to treat chronic myelogenous leukemia. It is an established small molecule inhibitor of Abl family tyrosine kinases that include both Abl and Arg (Ablrelated gene) kinases (Buchdunger et al., 1996; Carroll et al., 1997; Lu et al., 2002) . STI571 also shows an inhibitory effect on the PDGF receptor tyrosine kinase in fibroblast cells (Buchdunger et al., 2000) .
In control cells the typical formation of lamellipodial structures from the spherical cell body occurs by 0.5 DIV (Fig. 1 A) . This is followed by the extension of multiple neurites, one of which assumes axonal identity, by 3 DIV. Between this point and 7 DIV, dendritic identity is established, and dendritic processes elongate and become more structurally complex while axonal outgrowth continues independently.
To examine the effects of Abl family kinase inhibition during dendrogenesis, we applied STI571 to hippocampal cultures between 4.5 and 7 DIV. This allowed us to examine the effects of Abl family kinase inhibition on dendrogenesis after the axonal identity had been established fully. After 24 hr STI571 treatment resulted in a reduction of dendrite length as well as a corresponding attenuation of branch formation ( Fig. 1 B, arrows point to dendrites; arrowheads point to the axon). This trend continued through 6 DIV, when dendrite length and branch formation both were decreased markedly. By 7 DIV dendritic development was inhibited, and degeneration was apparent ( Fig. 1 B, arrows) . We also noted the appearance of cell body rounding, an effect of Rho activation in a number of different cell types, including neuronal cell lines (Leeuwen et al., 1997; Kranenburg et al., 1999) . The effects of STI571 on dendrogenesis were specific for Abl family tyrosine kinases, because treatment with 5 M AG1296 to inhibit PDGF receptor tyrosine kinase (IC 50 ϭ 0.5 M) did not show any effects on dendrogenesis. The effects of STI571 on dendrogenesis were dose-dependent, because 60 nM had little impact whereas maximum inhibition was achieved at 5 M treatment. In addition, STI571 effects were limited to actively developing dendritic structures and were reversible, because dendrogenesis resumed and showed no significant difference by 10 DIV when STI571 was withdrawn on 7 DIV (data not shown). We noted that Abl kinase inhibition had a less striking effect on axon morphology after establishment of axonal identity. Axon growth and branch formation continued in both control and STI571 treatments ( Fig.  1 A,B) . On 7 DIV, although there were no significant differences in axon length and branch points between control and STI571-treated neurons, STI571 led to a remarkably reduced dendritic number and length (Table 1) . On the other hand, overexpression of a constitutively active Abl (CA-Abl) resulted in an overall increase in dendritic complexity (dendritic branching and extension), especially the primary dendrite number and length (Table  1 ). These data indicate that Abl family kinases play an important role in the formation of dendritic arbor and that this involvement may be separate from axonogenesis.
Inhibition of Abl family tyrosine kinase activity alters the developmental dynamics of dendrogenesis
To examine the dynamics of dendrogenesis influenced by Abl kinase inhibition, we used time-lapse microscopic imaging. Control neurons treated with DMSO at 7 DIV displayed rapid motility of primary and secondary dendrites as well as extension and retraction of dendritic sprouts. We designated the primary dendrites as those processes longer than 10 m that extended directly from the neuronal cell body. Secondary dendrites were those that branched off directly from the primary dendrites.
Because the major measurable changes in dendritic dynamics of neurons treated with DMSO or STI571 in 7 DIV neurons were proximal to the cell body, we focused on the dendrite activities within the 120 m 2 brackets. After a 135 min recording experiment the control dendrite length increased significantly ( Fig. 2 A, asterisks point to the extension of one such dendrite). During this time period an individual dendrite can elongate and retract for a few minutes, followed by a major advance (Fig. 2 B) . For example, two major advances can be demonstrated in the average life history of 25 dendrites ( Fig. 2 B, DMSO at 40 and 90 min, respectively). At 7 DIV primary dendrites extended at a slower rate, giving a 22% increase in length, whereas secondary dendrites elongated rapidly, leading to a 44.8% increase in length at the end of the recording period (Fig. 2C, DMSO) . In contrast, although individual secondary dendrites in neurons treated with STI571 from 5 to 7 DIV showed a modest elongation ( Fig. 2 A, arrowhead), the length of most dendrites remained unchanged or was decreased slightly (Fig. 2 A, number symbol points to a retracting dendrite). This resulted in no overall elongation of primary dendrites. Secondary dendrites showed a small (9.8%) but insignificant increase in length ( Fig. 2 B,C) . We also evaluated dendritic sprout formation in DMSO-and STI571-treated neurons as a measure of dendritic complexity. Although dendritic sprout numbers remained unchanged in both control and STI571-treated neurons before and after recording, there were significantly fewer sprouts in STI571-treated neurons when compared with control cells (Fig. 2 A,D) . Thus, although sprout formation did occur under conditions of Abl kinase inhibition during the 135 min time-lapse recording, additional extension was limited, leading to a net retraction and subsequent reduction in dendrite complexity (Fig. 2 A) . As with previous experiments, no significant differences in axonal outgrowth were noted in response to Abl kinase inhibition after axonal establishment. Under this experimental condition there were no changes in lamellipodia motility of growth cone dynamics in DMSO-or STI571-treated neurons ( Fig. 2A, arrowheads) (for additional information on growth cone and dendrite dynamics by time-lapse video light microscopy, see supplemental material, available at www.jneurosci.org). These experiments suggest that Abl kinase inhibition may impair the function of molecular machinery required for dendritic branching, which is highly active at 7 DIV.
Inhibition of Abl family tyrosine kinases disrupts axon-dendrite polarity
To determine whether the cytoskeletal organization of hippocampal neurons is altered by the inhibition of Abl tyrosine kinases, we performed double-immunofluorescent light microscopy. At 7 DIV the control neurons showed an elaborate dendritic arbor, which was supported by the underlying actin network (Fig. 3Aa, arrows) . Microtubule-associated protein 2 (MAP2), which is specific for dendrite localization, was clearly present in the dendrites (Fig. 3Ab, arrows) but excluded from the axon (Fig. 3Ab, arrowhead) . Microtubule-associated protein Tau, known to segregate into the axonal compartment, was present in the axon (Fig. 3Ac, arrowhead) but only weakly visible in the dendrites (Fig. 3Ac, arrows) . However, neurons treated with STI571 from 4.5 to 7 DIV showed localized enrichment of actin filament at the growth cones of axons (Fig. 3Ba, asterisk) and dendrites (Fig. 3Ba, arrows) . A weak anti-MAP2 immunostaining was seen in the dendrites, but it also became positive in the axon, indicating the failure of MAP2 segregation (Fig. 3Bb , arrows indicate dendrites; arrowhead points to the axon). The disruption of normal axon-dendrite polarity was evident, because Tau protein not only was present in the axon (Fig. 3Bc , arrowhead) but also was observed in the dendrites (Fig. 3Bc,  arrows) .
To determine whether the disruption of dendritic polarity is MAP2-specific, we examined the distribution patterns of CD71 (transferrin receptor) and the glutamate receptor, two other well established dendritic markers in hippocampal cultures (West et al., 1997; Li et al., 1998) . At 7 DIV the MAP2 and the transferrin receptor showed overlapping staining patterns in control neurons (Fig. 4 , DMSO, MAP2, and CD71 arrows). When 5 DIV neurons were treated with STI571 for 48 hr, the transferrin receptor was codistributed with MAP2 in all processes, and dendritic deterioration was obvious (Fig. 4, STI571 , MAP2, and CD71). NR2A, a regulatory subunit of the NMDA subtype ionotropic glutamate receptor, began to express and localize to the dendrites of 7 DIV hippocampal neurons (Fig. 4 , DMSO, NR2A arrow). This can be confirmed by double-labeling neurons with anti-Tau, which showed a complementary staining pattern to NR2A (Fig. 4 , DMSO, Tau arrowhead). When neurons were treated with STI571 for 48 hr, NR2A and Tau were present in all of the processes (Fig. 4, STI571, NR2A , Tau). The phenotype for a decrease in dendrite number and length in neurons immunostained with A total of 18 neurons from at least two independent transfection experiments were analyzed for their axon and dendrite number and length. A total of 40 neurons were scored for nuclear condensation using Hoechst staining. Each number represents the percentage (mean Ϯ SEM) of DMSO as the control. *Significantly different from control, p Ͻ 0.05.
anti-transferrin receptor and anti-NR2A was similar to degenerating neurons stained with anti-MAP2. This result showed that STI571-induced dendritic degeneration is not limited to the alteration of MAP2 but that the distribution and segregation of other dendritic-specific markers also are affected.
Abl family tyrosine kinase activity influences primary dendrite formation and secondary dendritic branching
To examine further the effect of Abl kinase activity on morphological features of dendrite formation, we quantified the dendritic characteristics, such as primary dendrite formation and secondary dendrite branching, in response to Abl kinase inhibition and overexpression of CA-Abl (Fig. 5 ). All quantification was based on MAP2-positive staining to differentiate dendritic processes. Phase-contrast and immunofluorescent light microscopy of single neurons showed that the endogenous Abl expression was present throughout the neuronal cell body and the processes (Fig. 5A , DMSO and STI571), although the immunostaining was weak when compared with the intensive Abl immunoreactivity of the cells transfected with CA-Abl (Fig.  5A , CA-Abl). STI571 treatment reduced the number of MAP2-positive primary dendrites when compared with DMSO-treated neurons (Fig. 5A , DMSO and STI571). In contrast, CA-Abl overexpression induced an exuberant formation of MAP2-positive dendrites (Fig. 5A , CA-Abl). To quantify the number of dendrites per neuron and measure the length of dendrites, we applied the Region Function of MetaMorph imaging software. Dendrites within the area of 120 m 2 were scored. When compared with the control, Abl inhibitor-treated neurons showed a 42% reduction in primary dendrite number and 45% reduction in secondary dendrite number per cell (Fig. 5B) . This is in contrast to neurons overexpressing CA-Abl, in which the primary dendrite number increased by 20% (Fig. 5B) . The effects of CA-Abl overexpression appeared to influence primary dendrites more dramatically, because the number of secondary dendrites in these neurons did not differ significantly when compared with control neurons (Fig. 5B) . We also examined the effect of Abl kinase activity on the relative length of primary and secondary dendrites (Fig. 5C ). Compared with control neurons, STI571-treated neurons showed a modest decrease in primary dendrite length by 15% and secondary dendrite length by 17%. CA-Abl overexpression led to an increase in primary dendrite length by 15% but had little effect on secondary dendrite length. In addition, the number of dendrites may be overestimated slightly in STI571-treated neurons because, in some neurons, axons could be mistaken for dendrites as they became MAP2-positive (Fig. 3B) . These analyses demonstrated that a balanced Abl tyrosine kinase activity is important in maintaining a physiological pace of dendrogenesis.
Inhibition of Abl family tyrosine kinase activity leads to an increase in GTPbound RhoA without affecting Rac1 or Cdc42 activity The morphological features observed with modulation of Abl kinase activity are reminiscent of those induced by the Rho family of small GTPases, which are important regulators of many aspects of neurogenesis, including dendrogenesis. RhoA has been reported widely to regulate dendrite outgrowth negatively, whereas Rac1 and Cdc42 have been shown to increase dendrite length and complexity (Katoh et al., 1998; Lee et al., 2000; Luo, 2000; Nakayama et al., 2000) . To determine whether the activity of Rho family small GTPases is affected by the inhibition of Abl kinase activity, we used an affinity precipitation technique to quantitate active (GTP-bound) Rho GTPases (Benard et al., 1999; Ren et al., 1999) . Primary neuronal cultures were subjected to a series of pharmacological treatments before evaluation of Rho GTPase activity. When 5 DIV neurons were treated with DMSO as a control for 48 hr, a basal level of active RhoA, Rac1, and Cdc42 could be detected (Fig. 6 A, right, DMSO) . STI571 treatment increased RhoA activity but did not induce significant changes in Rac1 or Cdc42 activity (Fig. 6 A, right, STI571 ). Toxin B, a well established inhibitor of Rho GTPase activity, suppressed GTP-bound RhoA, Rac1, and Cdc42 (Fig. 6 A, right, Toxin B) . We treated neurons with STI571 in the presence of hydrogen peroxide as a positive control because it additionally enhanced RhoA activity (Fig. 6 A, right, STI571 plus H 2 O 2 ). Glutamate treatment leads to actin remodeling in dendritic spines, and the stimulus-induced dendritic arbor growth requiring glutamate receptor-mediated synaptic transmission has been shown to increase Rac1 and Cdc42 activity (Fischer et al., 2000; Jones et al., 2002; Sin et al., 2002; Portera-Cailliau et al., 2003) . We therefore subjected neurons at 7 DIV to 100 M glutamate for 10 min. Compared with DMSO-or STI571-treated neurons, a brief treatment of glutamate induced an activation of Rac1, but not Cdc42 (Fig. 6A , right, glutamate). As a control, 7 DIV cell lysates with different treatments were probed with anti-RhoA, Rac1, or Cdc42 to show that the protein expression of these GTPases did not change (Fig. 6A, left) . Semiquantification using Bio-Rad GelDoc showed that STI571 resulted in a 30% increase in RhoA activity, whereas the changes in Rac1 and Cdc42 activity were insignificant (Fig. 6B) . Taken together, these data indicate that RhoA may be a downstream target of Abl kinase activity, whereas Rac1 and Cdc42 may not be targeted directly in 7 DIV hippocampal neurons.
Rho kinase inhibition suppresses the inhibitory effects of STI571 on dendrogenesis
Although RhoA has many downstream effectors, Rho-associated kinase or p160/ROCK has been shown to be particularly important in neuronal morphogenesis. This is demonstrated in several studies that have shown that RhoA-mediated neurite retraction can be prevented by inhibition of ROCK activity (Hirose et al., 1998; Bito et al., 2000; Nakayama et al., 2000) . Because morphological and biochemical data suggest an association of the Abl family kinases and RhoA signaling, we speculated that ROCK also may lie downstream of Abl. To examine this more closely, we used Y-27632, a ROCK-specific inhibitor (Uehata et al., 1997) , to determine whether the STI571-induced dendritic simplification can be reversed when ROCK activity is blocked. Doubleimmunofluorescent light microscopy of single neurons demonstrated that 7 DIV neurons showed an elaborate MAP2-positive dendrite formation and displayed a well defined F-actin network (Fig. 7A , STI571/Ϫ and Y-27632/Ϫ). STI571 treatment suppressed dendritic elaboration, which is characterized by a reduced number of MAP2-positive dendrites. The fluorescent phalloidin staining showed an increased focal F-actin organization (Fig. 7A , STI571/ϩ and Y-27632/Ϫ, arrowheads), although its overall intensity was decreased in dendrites (Fig. 7A , STI571/ϩ and Y-27632/Ϫ) (here the image of F-actin staining was enhanced to show dendritic number and length). Neurons treated with 10 M Y-27632 alone resulted in an increase in dendrite length (Fig. 7A, STI571 /Ϫ and Y-27632/ϩ). When it was compared with STI571 treatment alone, STI571 in the presence of Y-27632 elicited a reversal of dendritic simplification toward the level of arborization seen in control cells (Fig. 7A, STI571 /ϩ and Y-27632/ϩ).
When the effect of Y-27632 on dendrogenesis was quantified, it became clear that, although STI571 inhibited both the numbers of primary and secondary dendrites, Y-27632 was able to suppress the effect of STI571 (Fig. 7B) . Y-27632 treatment alone did not affect the number of primary and higher order dendrites significantly. STI571 also reduced the length of both primary and secondary dendrites when compared with neurons treated with DMSO as the control (Fig. 7C) . Y-27632 treatment alone, however, increased the dendrite length dramatically. Neurons treated with Y-27632 reversed the inhibitory effect of STI571 on the length of secondary dendrites but additionally promoted the length of primary dendrites when compared with neurons treated with DMSO. The ability of Y-27632 to reverse STI571 effects on dendrites was rather extensive, because Y-27632 was applied to neurons previously treated with STI571 for 24 hr. Thus our results indicate that Abl kinase activity indeed plays a critical role in the upstream regulation of both RhoA and its downstream effector ROCK during dendrogenesis.
RhoA activation suppresses CA-Abl effect on dendrogenesis
In addition to the simplification of the dendritic tree that was observed with the inhibition of the Abl family kinases, we also found a reciprocal increase in dendritic complexity with overexpression of a constitutively active Abl kinase (Fig. 5) . If Abl kinase activity negatively regulates RhoA, it stands to reason that expression of constitutively active RhoA may be sufficient to block the phenotype seen with Abl kinase activation. To test this hypothesis, we coexpressed CA-Abl and constitutively active RhoA (CARhoA) in hippocampal neurons (Fig. 8) . Constitutive activation of Abl kinase induced an exuberant formation of dendritic arbors (Fig. 8 , pEGFP-C2/ϩ and CA-Abl/ϩ) (also Fig. 5A , CA-Abl). Consistent with previous reports, CA-RhoA was sufficient to induce dendrite retraction and resulted in a drastic simplification of the dendritic arbor (Fig. 8 , CA-Abl/Ϫ and CA-RhoA-GFP/ϩ) (Nakayama et al., 2000) . When CA-RhoA and CA-Abl were coexpressed, we observed a complete reversal of the CA-Abl phenotype to that seen with CA-RhoA alone (Fig. 8 , CA-Abl/ϩ and CA-RhoA-GFP/ϩ). Overall, these data indicate that the activity of Abl kinase plays a critical role in the regulation of dendrite elaboration during dendrogenesis via a RhoA/ROCK-dependent mechanism.
The CA-Abl effect on dendrogenesis is dependent on the reorganization of the actin cytoskeleton but is independent of microtubule stability Modulation of Abl kinase activity appears to signal through RhoA and ROCK, both of which have been shown to be essential in the regulation of actin stability and neurite sprouting (Da Silva et al., 2003) . We have speculated that Abl kinase activity also may affect the underlying cytoskeletal structure of primary neurons in association with RhoA/ROCK-dependent signaling. To examine this more closely, we pharmacologically modified the actin cytoskeleton in conjunction with overexpression of CA-Abl kinase to determine whether the CA-Abl phenotype is dependent on reorganization of actin (Fig. 9A) . After microfilament destabilization with latrunculin A alone, F-actin was fragmented, and we noted an increase in neuronal process formation, which resembles the phenotype generated by CA-Abl (Fig. 9A , compare F-actin in neurons treated with CA-Abl/ϩ and latrunculin A/ϩ). Treatment with latrunculin A, in conjunction with CA-Abl overexpression, yielded a phenotype similar to both treatments individually, which indicates the requirement for actin disruption in process formation in response to Abl activation (Fig. 9A , CAAbl/ϩ plus latrunculin A/ϩ). F-actin staining became fragmented because of the effects of latrunculin A treatment. In the reverse experiment we used jasplakinolide, a cell-permeable macrocyclic peptide that is a potent inducer of actin polymerization, to determine whether the CA-Abl phenotype can be blocked by stabilization of the actin cytoskeleton. Treatment with jasplakinolide alone resulted in a simplification of dendritic branching (Fig. 9A, jasplakinolide/ϩ) . When CA-Abl expression was combined with jasplakinolide treatment, the dendritic branching became less extensive than in neurons expressing CA-Abl without jasplakinolide treatment (Fig. 9A , jasplakinolide/ϩ plus CAAbl/ϩ). We noticed that F-actin staining was weak in neurons treated with jasplakinolide or jasplakinolide plus CA-Abl expression. This was attributable to the competition of jasplakinolide with rhodamine phalloidin for F-actin binding.
When the dendritic number and length were quantified, it became apparent that CA-Abl expression increased both primary dendritic number and length, whereas destabilization of F-actin by latrunculin A promoted primary dendrite number but inhibited dendrite extension (Fig. 9B,C) . Treatment of neurons with jasplakinolide showed no significant change in dendritic length but did show a reduction in dendritic branching. These data suggest that F-actin destabilization facilitates dendritic formation and branching. In addition, CA-Abl expression under the background of latrunculin A treatment did not show any additional effects on dendritic branching and only slightly reversed the effects of latrunculin A on dendrite length, suggesting that latrunculin A effects may be more dominant than CAAbl expression (Fig. 9B,C) . Interestingly, CA-Abl expression under the background of jasplakinolide reversed the inhibitory effects of jasplakinolide on dendritic branching but reduced dendritic length. This result suggests that dendritic elongation was limited during the rapid induction of dendrite outgrowth, which is consistent with the process of dendritic arbor formation in vivo. Together, these studies indicate that Abl may function in a dendritic morphogenesis context by destabilizing the local actin cytoskeleton selectively.
We also addressed a possible role for microtubule stability in the CA-Ablinduced branching phenotype (Fig. 10) . When microtubules were depolymerized by vincristine treatment, MAP2 staining withdrew from dendritic processes and became localized to the perinuclear cytoplasm of the neuronal cell bodies (Fig. 9 , MAP2 staining in CA-Abl/Ϫ plus vincristine and CA-Abl/ϩ plus vincristine). However, neither control cell morphology nor the CA-Abl phenotypes were reversed, indicating that stabilized microtubules are not required for the maintenance of either morphology. These results are consistent with the hypothesis that the CA-Abl phenotype is dependent on the stability of the actin cytoskeleton but is independent of microtubule stability.
Discussion
Regulation of dendrogenesis by Abl family kinases
During development numerous signaling pathways interact to contribute to spatial and temporal regulation of morphogenesis, leading to the correct organization of the brain and the generation of synaptic circuits. Abl family tyrosine kinases contribute to several vital steps during this process, including neurulation and axonogenesis. In this study we attempted to elucidate the contribution of Abl kinases to dendrogenesis, a role for which has not been addressed fully. Treatment with STI571, a small molecule inhibitor of Abl family kinases, altered the developmental dynamics of dendrogenesis in primary rat hippocampal cultures and resulted in a significant simplification of dendritic structure. This outcome ap- pears to be independent of axonogenesis, because STI571 treatment occurring after axonal establishment did not have significant effects on continuing axon growth.
We recognize that STI571 also can inhibit PDGF receptor tyrosine kinase in vitro and in fibroblast cells (Carroll et al., 1997; Buchdunger et al., 2000; Simakajornboon et al., 2001 ). However, AG1296, a selective inhibitor for PDGF receptor, did not affect dendrogenesis. In addition, overexpression of a constitutively active Abl kinase resulted in the outgrowth of an abundant number of highly branched MAP2-positive processes. From these data we conclude that the Abl family members do play a role in dendrogenesis in which kinase activity positively regulates dendrite outgrowth and branching.
The mammalian Abl family of nonreceptor tyrosine kinases is composed of c-Abl and Arg, which are encoded by the abl1 and abl2 genes, respectively. Targeted disruption of abl1 and abl2 does not yield discernible phenotypic changes in the context of neuronal morphology (Schwartzberg et al., 1991; Tybulewicz et al., 1991; Koleske et al., 1998) . In hippocampal cultures the expression of an Abl kinase-inactive K(290)R mutant (Yuan et al., 1997) showed a moderate trend of reducing dendrite number and length that was statistically insignificant (S. B. Jones and Q. Lu, unpublished results) . Similarly, the expression of kinase-inactive Arg did not have significant effects on the morphology of neuronal N2A cells (Hernandez et al., 2004) . This indicates that the suppression of both Abl and Arg kinase activities is required to show a significant inhibitory effect on dendrogenesis. Unfortunately, abl/arg double knock-out mice die before embryonic day 11, precluding any application of extracting neurons to generate hippocampal cultures (Koleske et al., 1998) . Therefore, the ability of STI571 to inhibit selectively both Abl and Arg kinases provides an opportunity to investigate their roles in neuronal development. Our results, focused on the development of dendritic structures, are consistent with previous reports that STI571 treatment during earlier developmental time points resulted in shorter, less branched neurites and that an increase in neurite length occurs with Ablactivation(Zukerbergetal.,2000; Woodring et al., 2002) .
Regulation of dendritic complexity by Abl family tyrosine kinases
A balance between dendrite formation and elongation is critical for the neurons to establish their complex arborization during brain development. Although Abl tyrosine kinase activation promotes both of these for 48 hr or with STI571 for 48 hr, followed by ST1571 plus H 2 O 2 for 10 min. The 6 DIV neurons were treated with Toxin B for 24 hr. The 7 DIV neurons were treated with 100 M glutamate for 10 min. The 7 DIV cell lysates with different treatments were probed with anti-RhoA, Rac1, or Cdc42 antibodies to show their expression levels (left panels). The 7 DIV cell lysates from different treatments also were incubated with GST-RBD (RhoA) or GST-PBD (Rac1 and Cdc42) glutathione beads to pull down GTP-bound RhoA, Rac1, or Cdc42 as an indication of their activities. Bound proteins were analyzed by Western blot with anti-RhoA, Rac1, or Cdc42 antibodies (right panels). B, Relative RhoA, Rac1, and Cdc42 activity was determined semiquantitatively by using densitometric analysis as described in Materials and Methods. Data represent the means Ϯ SEM of at least three independent experiments; *p Ͻ 0.05. events, the effects of Abl activation on dendritic formation seem to be more pronounced than on dendrite elongation. This may reflect the fact that the different signaling pathways could regulate dendrite elongation and branching separately. This may not be unique for Abl regulation of dendrogenesis. For example, ␦-catenin, a dendrite-specific postsynaptic density protein , binds to cortactin when dephosphorylated at Src tyrosine kinase sites and promotes an unbranched primary processes. On the other hand, when RhoA is inhibited, ␦-catenin enhances the effects of Rho inhibition on branching (Martinez et al., 2003) . In our unpublished studies we found that the inhibition of presenilin-1/␥-secretase activity induced an exuberant extension of dendrites without significantly affecting dendrite numbers, indicating that the regulation of dendrite formation and elonga- tion may be separable. These results appear to echo a dendritic growth model proposed previously in which a single stochastic growth algorithm indicated that, when dendrites actively are forming branches, there is a temporary suppression of additional branching during dendritic arbor formation (Nowakowski et al., 1992) .
Regulation of RhoA/ROCK by Abl family kinases Our findings led us to question the mechanism by which Abl activity may impact dendrogenesis. Abl kinases are known to organize actin rearrangement both directly, via binding domains for G-actin and F-actin, and indirectly, via interactions with downstream signaling partners Woodring et al., 2003) . One group of proteins that seems to be particularly important in many aspects of neuronal development, including dendrogenesis, is the Rho family of small GTPases. In general, RhoA is known to impact neurite outgrowth negatively, whereas Rac1 and Cdc42 increase neurite outgrowth and complexity. Interestingly, we note that inhibition of Abl kinase activity leads to an increase in the activity of RhoA but has no effect on Rac1 or Cdc42 activation. In addition to an increase in RhoA activity, STI571-induced dendritic simplification can be reversed by inhibition of ROCK, a primary downstream effector of RhoA in neurons (Hirose et al., 1998; Bito et al., 2000; Nakayama et al., 2000) . Conversely, coexpression of CA-RhoA and CA-Abl is sufficient to suppress CA-Ablgenerated increases in dendrite complexity. These data are consistent with the hypothesis that Abl positively regulates dendrogenesis by inactivating RhoA, which leads to a commensurate decrease in ROCK activity and subsequent increases in dendrite outgrowth and branching.
Regulation of the actin cytoskeleton during dendrogenesis by Abl family kinases
The Abl family kinases are involved in the reorganization of the actin cytoskeleton in a variety of cellular processes. Their roles in neurulation, axon outgrowth, growth cone motility, and neurite branching make them crucial to normal brain development. Here we present evidence that Abl kinase activity is additionally important in cytoskeletal events that underlie dendrogenesis. We found that actin depolymerization with latrunculin A is sufficient to induce the outgrowth of numerous neuritic processes, which are reminiscent of increased dendritic complexity generated by overexpression of CA-Abl kinase. Interestingly, when CA-Ablexpressing cells are subjected to latrunculin A treatment, no additional elaboration of dendritic arbors occurs. Conversely, actin stabilization with jasplakinolide is able to reverse partially the CA-Abl-induced processes. This suggests that Abl activity leads to actin destabilization, which induces dendrite formation. The actin depolymerization has been demonstrated as an important step in promoting neurite extension (Bradke and Dotti, 1999) , especially in the context of regulation by proteins of the actindepolymerizing factor (ADF)/cofilin family . It is interesting to note that, although CA-Abl expression promotes both dendritic extension and branching, latrunculin A treatment promotes dendrite formation while inhibiting dendrite length. Conversely, jasplakinolide treatment has no significant effect on dendrite length but significantly reduces dendritic numbers. In addition, CA-Abl expression was able to reverse the effects of jasplakinolide on dendritic number and, in doing so, limited dendritic elongation. This may be attributable to the inability of actin polymerization to accommodate a rapid increase in dendrite number concurrent with significant elongation. The cellular mechanism regulating the control of dendrite number and length is complex and will require additional investigation. Therefore, it would be important to caution that a sustained destabilization of actin polymerization should limit growth cone activity and suppress neurite extension. Indeed, it is conceivable that actin polymerization and depolymerization must be regulated tightly and locally so that a coordinated formation and extension of neurites can lead to an ultimate establishment of physiologically sound dendritic arbors in vivo. Ample literature exists that demonstrates a variety of extracellular cues in directing the extension and retraction of growth cones and neurites (Liu and Strittmatter, 2001; Gallo and Letourneau, 2004) . In addition, intracellular signaling molecules such as Rho family small GTPases regulate local actin cytoskeletal organizations (Kuhn et al., 2000; Luo, 2000) . Taken together, our data are consistent with recent studies that demonstrate the importance of RhoA/ROCKdependent actin destabilization in neurite sprouting and axon formation (Bradke and Dotti, 1999; Bito et al., 2000; Da Silva et al., 2003) . Thus we propose that Abl family kinases regulate dendrogenesis in developing hippocampal cultures by effecting actin reorganization via a RhoA/ROCK-dependent pathway. Figure 10 . The CA-Abl effect on dendrogenesis is independent of the stability of microtubules. Shown is doubleimmunofluorescent light microscopy of single neurons by rabbit polyclonal anti-Abl antibody (top) and mouse monoclonal anti-MAP2 (bottom). Control hippocampal neurons or CA-Abl-expressing cells were incubated with or without the presence of 5 M vincristine for 5 hr. Note that the MAP2-positive microtubules were disorganized in the neurons treated with vincristine, which shows no significant effects on the dendrite morphology. Scale bar, 15 m.
